FAM
Fred Alger Management Portfolio holdings
AUM
$22.3B
1-Year Return
57.87%
This Quarter Return
-20.08%
1 Year Return
+57.87%
3 Year Return
+264.72%
5 Year Return
+406.03%
10 Year Return
+1,631.73%
AUM
$21.4B
AUM Growth
-$9.89B
(-32%)
Cap. Flow
-$2.29B
Cap. Flow
% of AUM
-10.68%
Top 10 Holdings %
Top 10 Hldgs %
28.78%
Holding
568
New
77
Increased
161
Reduced
233
Closed
68
Top Buys
| 1 |
McKesson
MCK
|
$223M |
| 2 |
Costco
COST
|
$156M |
| 3 |
Live Nation Entertainment
LYV
|
$155M |
| 4 |
Datadog
DDOG
|
$151M |
| 5 |
ServiceNow
NOW
|
$132M |
Top Sells
| 1 |
Apple
AAPL
|
$305M |
| 2 |
NVIDIA
NVDA
|
$280M |
| 3 |
Microsoft
MSFT
|
$220M |
| 4 |
Expedia Group
EXPE
|
$134M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$134M |
Sector Composition
| 1 | Technology | 33.04% |
| 2 | Healthcare | 20.62% |
| 3 | Consumer Discretionary | 12.69% |
| 4 | Industrials | 10.49% |
| 5 | Financials | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
Halozyme
HALO
$8.59B
| $442K | ﹤0.01% |
+10,050
| New | +$442K |
|
402
MaxCyte
MXCT
$145M
| $434K | ﹤0.01% |
91,759
-1,835
| -2% | -$8.68K |
|
403
Vinci Compass Investments Ltd. Class A Common Shares
VINP
$635M
| $433K | ﹤0.01% |
40,470
-8,500
| -17% | -$90.9K |
|
404
Arhaus
ARHS
$1.6B
| $425K | ﹤0.01% |
94,341
-1,846
| -2% | -$8.32K |
|
405
Xylem
XYL
$34.5B
| $421K | ﹤0.01% |
5,388
-362
| -6% | -$28.3K |
|
406
SBA Communications
SBAC
$21B
| $379K | ﹤0.01% |
1,183
-461
| -28% | -$148K |
|
407
Sana Biotechnology
SANA
$757M
| $370K | ﹤0.01% |
+57,506
| New | +$370K |
|
|
SOVO
408
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $367K | ﹤0.01% |
+23,122
| New | +$367K |
|
409
Allegion
ALLE
$14.7B
| $360K | ﹤0.01% |
3,677
| – | – |
|
410
Kura Oncology
KURA
$706M
| $349K | ﹤0.01% |
+19,054
| New | +$349K |
|
411
W.W. Grainger
GWW
$49.2B
| $330K | ﹤0.01% |
727
+689
| +1,813% | +$313K |
|
412
Freeport-McMoran
FCX
$66.1B
| $327K | ﹤0.01% |
11,181
-1,363,594
| -99% | -$39.9M |
|
413
Rockwell Automation
ROK
$38.4B
| $319K | ﹤0.01% |
1,603
| – | – |
|
414
Repare Therapeutics
RPTX
$72.6M
| $319K | ﹤0.01% |
+22,772
| New | +$319K |
|
415
Standard BioTools
LAB
$493M
| $313K | ﹤0.01% |
195,490
-204,798
| -51% | -$328K |
|
416
Levi Strauss
LEVI
$8.92B
| $300K | ﹤0.01% |
18,405
| – | – |
|
417
Cartesian Therapeutics
RNAC
$260M
| $290K | ﹤0.01% |
+7,374
| New | +$290K |
|
|
TBIO
418
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $275K | ﹤0.01% |
8,503
-174
| -2% | -$5.63K |
|
419
Align Technology
ALGN
$9.76B
| $272K | ﹤0.01% |
1,151
| – | – |
|
420
Workday
WDAY
$61.7B
| $267K | ﹤0.01% |
1,910
| – | – |
|
421
Denali Therapeutics
DNLI
$2.16B
| $264K | ﹤0.01% |
+8,983
| New | +$264K |
|
422
Veracyte
VCYT
$2.48B
| $258K | ﹤0.01% |
+12,943
| New | +$258K |
|
|
IGMS
423
DELISTED
IGM Biosciences
IGMS
| $218K | ﹤0.01% |
12,067
-73,542
| -86% | -$1.33M |
|
424
Biodesix
BDSX
$65M
| $215K | ﹤0.01% |
130,908
-2,607
| -2% | -$4.28K |
|
425
Tenet Healthcare
THC
$17B
| $209K | ﹤0.01% |
3,985
-409,024
| -99% | -$21.5M |
|